QA: OCULAR THERAPEUTIX INC in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001393434_2020_OCULAR_THERAPEUTIX_INC.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001393434, OCULAR THERAPEUTIX INC

  xvar xval
0 AssetsCurrent 60,170,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 10,151,000
3 remainder_Assets 8,419,000
4 LiabilitiesCurrent 12,029,000
5 LiabilitiesNoncurrent 8,905,000
6 remainder_Liabilities 61,436,000
7 CostOfGoodsAndServicesSold 2,325,000
8 SellingGeneralAndAdministrativeExpense 22,122,000
9 ResearchAndDevelopmentExpense 41,091,000
10 remainder_Expenses 24,491,000
11 remainder_Revenues 4,227,000
12 remainder_NetIncome -570,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 78,740,000
1 Liabilities 82,370,000
2 Expenses 90,029,000
3 Revenues 4,227,000
4 StockholdersEquity -3,630,000
5 NetIncome -86,372,000
6 ComprehensiveNetIncome -86,372,000
7 BaseVar 127,968,000
8 EconomicCapitalRatio -1.15

Edgar->Model Mapping

Feature Distribution

Change over Time